This article is based on a debate that took place during the European School of Oncology (ESO) Inside Track Conference "Breast Cancer in Young Women (BCY1)" which took place from 8 -10 th November 2012 in Dublin, Ireland.
No takes yet. Share an insight, caveat, or question.
Colleoni et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: